103 related articles for article (PubMed ID: 2949164)
1. [Antiplatelet activity of picotamide in patients with chronic vascular pathology].
Coto V; Carrieri P; Cocozza M; Oliviero U; Picano T; Spinoli G; Cacciatore L
Minerva Cardioangiol; 1986 Sep; 34(9):601-4. PubMed ID: 2949164
[No Abstract] [Full Text] [Related]
2. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
Craveri A; Colombo L; Cristina M; Coloru M; De Angeli B; Lanfredini M
Clin Ter; 1991 Jan; 136(1):23-9. PubMed ID: 1826869
[TBL] [Abstract][Full Text] [Related]
3. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
Canonico V; Ammaturo V; Guarini P; Tedeschi C; Nunziata G; Nappi A; Forgione L; Rengo F
Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of angioxine to the vascular protection of the diabetic].
Journ Annu Diabetol Hotel Dieu; 1976 May; ():319-27. PubMed ID: 796526
[No Abstract] [Full Text] [Related]
5. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
[TBL] [Abstract][Full Text] [Related]
6. Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
Gresele P; Migliacci R
Eur Heart J; 2004 Oct; 25(20):1769-71. PubMed ID: 15474690
[No Abstract] [Full Text] [Related]
7. [Picotamide: prevention and therapy of diabetic vasculopathies. A double-blind clinical study].
Pibiri L; Petruzzo P; De Giudici A; Brotzu G
Clin Ter; 1990 May; 133(4):233-7. PubMed ID: 2142911
[TBL] [Abstract][Full Text] [Related]
8. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
Neri Serneri GG; Coccheri S; Marubini E; Violi F;
Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
Neirotti M; Molaschi M; Ponzetto M; Macchione C; Poli L; Bonino F; Fabris F
Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
[TBL] [Abstract][Full Text] [Related]
10. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
Verstraete M
Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423
[No Abstract] [Full Text] [Related]
11. Picotamide, selective inhibitor of thromboxane synthesis in patients on maintenance hemodialysis.
Vandelli L; Grosoli M; Lusvarghi E; Cenci AM; Campioli D; Grossi G
Nephrol Dial Transplant; 1989; 4(12):1083-4. PubMed ID: 2517331
[No Abstract] [Full Text] [Related]
12. [Clinical study of picotamide in patients with vascular diseases].
Speziale F; Taurino M; Colella E; Rizzo L; Fiorani P
Recenti Prog Med; 1989 May; 80(5):271-5. PubMed ID: 2762664
[TBL] [Abstract][Full Text] [Related]
13. [Significance of the determination of beta-thromboglobulin. Experience with coronary sclerosis, and diabetes].
Udvardy M; Pfliegler G; Misz M; Boda Z; Rák K
Orv Hetil; 1983 Jul; 124(30):1797-800. PubMed ID: 6194493
[No Abstract] [Full Text] [Related]
14. Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
Milani M; Longoni A; Maderna M
Br J Clin Pharmacol; 1996 Dec; 42(6):782-5. PubMed ID: 8971437
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic activity of anti-platelet aggregation agents in arterial diseases].
Delboy C; Jouve R; Escande M; Juhan I; Bouvenot G
Sem Hop Ther; 1977 Nov; 53(9):431-40. PubMed ID: 341318
[No Abstract] [Full Text] [Related]
16. [Albatran: 3 years' experience with peripheral arteriopathies].
Elbaz C
Phlebologie; 1975; 28(4):611-7. PubMed ID: 1221446
[No Abstract] [Full Text] [Related]
17. Clinical efficacy of picotamide in long-term treatment of intermittent claudication.
Coto V; Cocozza M; Oliviero U; Lucariello A; Picano T; Coto F; Cacciatore L
Angiology; 1989 Oct; 40(10):880-5. PubMed ID: 2679241
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
Dotti GC
Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
[No Abstract] [Full Text] [Related]
19. Plasma beta-thromboglobulin levels and claudication degrees in patients with peripheral vascular disease.
Catalano M; Russo U; Libretti A
Angiology; 1986 May; 37(5):339-42. PubMed ID: 2424348
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Tebonin (extract from leaves of ginkgo biloba L.) in the treatment of senile peripheral arteriopathies].
Locatelli GR; Sorbini E
Minerva Cardioangiol; 1969 Dec; 17(12):1103-8. PubMed ID: 5373482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
